Abbott Laboratories (ABT) stock forecast for 2021. Forecast tables and graphs.

Abbott Laboratories (ABT) stock forecast for 2021

The forecast has been updated: September 16, 2021 8:42


Abbott Laboratories stock price online today

Analyst Target Price

121.06

Dividend Date

16.02.2021

Ex Dividend Date

14.01.2021

Last Split Factor

10000:4798

Last Split Date

02.01.2013

Should you buy or sell Abbott Laboratories stock stock today? What is the projected target price level for 2021? How much will it cost in 2021? Abbott Laboratories stock Stock Monthly Prediction for January, February, March, April, May, July, July, August, September, October, November and December 2021.

We predict the dynamics of the stock market value using resonant artificial intelligence systems.

Technical, fundamental analyzes, news background, general geopolitical situation in the world and other factors are taken into account.

Forecasts are adjusted once a day taking into account the price change of the previous day.

To date, analysts have a $121.06 target price for Abbott Laboratories stock stock.

Today 200 Day Moving Average is the support level (104.3559 $).

50 Day Moving Average is the support level (108.3297 $).




ABT Forecast for 2021

Month Rate Forecast MIN Rate MAX Rate Volati-
lity, %
Oct 128.92 124.59 136.34 8.62 %
Nov 126.55 123.10 133.43 7.74 %
Dec 128.57 125.90 131.04 3.92 %

The forecasts table above shows the forecast values of the company's stock price for each month. The Rate Forecast column displays the Optimal Average Forecast Price. The MIN Rate column displays a pessimistic forecast for this month. “MAX Rate” is an optimistic forecast. The % Volatility column represents the approximate monthly volatility of Abbott Laboratories stock.


Abbott Laboratories overview

Abbott Laboratories Address

100 Abbott Park Road, North Chicago, IL, United States, 60064

Market Capitalization

196 439 506 944 $

EBITDA

7 823 000 064

PE Ratio

58.6118

PEG Ratio

3.433

Dividend Per Share

1.8

Dividend Yield

0.0163

EPS

1.891

Quarterly Earnings Growth YOY

0.302

Quarterly Revenue Growth YOY

0.096

Trailing PE

58.6118

Forward PE

24.8139

EV To Revenue

6.431

EV To EBITDA

27.2256

52 Week High

115.14

52 Week Low

60.9114

50 Day Moving Average

108.3297

200 Day Moving Average

104.3559

Shares Outstanding

1772359936

Shares Float

1758413095

Shares Short Prior Month

11849490

Short Ratio

1.83

Percent Insiders

0.693

Percent Institutions

75.579

Abbott Laboratories stock forecast for this year


Abbott Laboratories stock forecast for Oct 2021.
Estimated Average Forecasted Abbott Laboratories Price: 128.92. Positive monthly dynamics of the instrument is expected with 8.624% volatility is expected.

Pessimistic forecast: 124.59

Optimistic: 136.34


Abbott Laboratories stock forecast for Nov 2021.
Estimated Average Forecasted Abbott Laboratories Price: 126.55. Negative monthly dynamics of the instrument is expected with 7.739% volatility is expected.

Pessimistic forecast: 123.10

Optimistic: 133.43


Abbott Laboratories stock forecast for Dec 2021.
Estimated Average Forecasted Abbott Laboratories Price: 128.57. Positive monthly dynamics of the instrument is expected with 3.925% volatility is expected.

Pessimistic forecast: 125.90

Optimistic: 131.04



Other Healthcare sector assets

Name Symbol Last Close Price Change
Abbott Laboratories
ABT 126.79 (17.09.2021) -0.51 %
AbbVie Inc.
ABBV 107.73 (17.09.2021) -0.32 %
Aeterna Zentaris Inc.
AEZS 0.6244 (17.09.2021) 1.64 %
Allakos Inc.
ALLK 109.18 (17.09.2021) 3.22 %
Allogene Therapeutics, Inc.
ALLO 25.38 (17.09.2021) 3.55 %
Amgen Inc.
AMGN 219.38 (17.09.2021) 0.93 %
Aphria Inc.
APHA 15.38 (07.05.2021) 0.00 %
Atara Biotherapeutics, Inc.
ATRA 16.08 (17.09.2021) 1.32 %
Aurora Cannabis Inc.
ACB 6.63 (17.09.2021) 0.15 %
Becton Dickinson and Company
BDX 261.95 (17.09.2021) -0.27 %
Biogen Inc.
BIIB 300.19 (17.09.2021) 0.17 %
Biohaven Pharmaceutical Holding Company Ltd.
BHVN 135 (17.09.2021) -1.41 %
BioNTech SE
BNTX 359.18 (17.09.2021) -3.61 %
bluebird bio, Inc.
BLUE 18.32 (17.09.2021) 3.62 %
Boston Scientific Corp.
BSX 44.37 (17.09.2021) -1.18 %
Bristol-Myers Squibb Company
BMY 61.31 (17.09.2021) 0.13 %
Canopy Growth Corp.
CGC 14.71 (17.09.2021) -0.81 %
Castle Biosciences, Inc.
CSTL 77.32 (17.09.2021) 1.46 %
CLOVER HEALTH INVESTMENTS, CORP
CLOV 8.31 (17.09.2021) 2.09 %
Eli Lilly and Company
LLY 230.1 (17.09.2021) -0.41 %
Emergent BioSolutions Inc.
EBS 57.14 (17.09.2021) -0.57 %
Exelixis, Inc.
EXEL 20.72 (17.09.2021) 0.88 %
G1 Therapeutics, Inc.
GTHX 15.55 (17.09.2021) 8.97 %
Gilead Sciences, Inc.
GILD 71.61 (17.09.2021) 0.39 %
GlaxoSmithKline plc
GSK 38.93 (17.09.2021) -0.46 %
GoodRx Holdings, Inc.
GDRX 46.98 (17.09.2021) 2.29 %
GW Pharmaceuticals plc.
GWPH 218.96 (05.05.2021) 0.00 %
Incyte Corp.
INCY 75.99 (17.09.2021) 1.27 %
Inovio Pharmaceuticals, Inc.
INO 8.14 (17.09.2021) 5.03 %
Johnson & Johnson
JNJ 164.75 (17.09.2021) -0.28 %
Medtronic plc.
MDT 129.7 (17.09.2021) -0.93 %
Merck & Co., Inc.
MRK 71.68 (17.09.2021) -0.40 %
Moderna, Inc.
MRNA 430.05 (17.09.2021) -2.41 %
Novartis AG
NVS 83.48 (17.09.2021) -1.07 %
Novavax, Inc.
NVAX 237.54 (17.09.2021) 0.11 %
ObsEva SA
OBSV 3.34 (17.09.2021) 8.44 %
OrganiGram Holdings Inc.
OGI 2.4 (17.09.2021) 0.00 %
Pfizer Inc.
PFE 43.89 (17.09.2021) -1.30 %
Regeneron Pharmaceuticals, Inc.
REGN 651.88 (17.09.2021) -0.20 %
Sanofi
SNY 48.38 (17.09.2021) 0.39 %
Schrodinger, Inc.
SDGR 62.42 (17.09.2021) 2.08 %
Senseonics Holdings, Inc.
SENS 3.81 (17.09.2021) -0.26 %
Sorrento Therapeutics, Inc.
SRNE 8.25 (17.09.2021) 2.10 %
Stryker Corp.
SYK 273.03 (17.09.2021) -1.12 %
Sundial Growers Inc.
SNDL 0.7254 (17.09.2021) 0.85 %
Teva Pharmaceutical Industries Lim. (TEVA)
TEVA 8.99 (17.09.2021) 0.45 %
Thermo Fisher Scientific Inc.
TMO 596.8 (17.09.2021) 6.49 %
Tilray, Inc.
TLRY 12.17 (17.09.2021) 1.33 %
UnitedHealth Group, Inc.
UNH 420.16 (17.09.2021) 0.80 %
Veeva Systems Inc.
VEEV 302.14 (17.09.2021) -0.94 %
Zomedica Corp.
ZOM 0.5242 (17.09.2021) -2.80 %
Zynerba Pharmaceuticals, Inc.
ZYNE 4.23 (17.09.2021) -2.08 %


Denial of responsibility:

The portal leoprophet.com is not responsible for the loss of your money as a result of your use of the information contained on the site, including data, quotes, charts and forecasts. Operations in the stock, foreign exchange and commodity markets involve a high level of risk, and you are solely responsible for your operations. Only speculate with money that you can afford to lose. All prices and forecasts for stocks, indices, futures are indicative and should not be trade dependent. The portal is not responsible for any losses that you may incur as a result of using this data.